Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07390838
What this trial is testing

SH009 Injection in Patients With Advanced Solid Tumors.

Who this might be right for
Liver Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)Head and Neck Cancer Squamous Cell Carcinoma+4 more
Nanjing Sanhome Pharmaceutical, Co., Ltd. 150
Testing effectiveness (Phase 2)UnknownNCT05594914
What this trial is testing

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of University of South China 47
Testing effectiveness (Phase 2)Study completedNCT00193284
What this trial is testing

Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
SCRI Development Innovations, LLC 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03110926
What this trial is testing

Induction Chemotherapy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
University of Rochester 40
Not applicableLooking for participantsNCT06530316
What this trial is testing

RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 48
Testing effectiveness (Phase 2)Ended earlyNCT00707655
What this trial is testing

Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma
Genmab 8
Large-scale testing (Phase 3)Ended earlyNCT01161498
What this trial is testing

Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer

Who this might be right for
Squamous Cell CarcinomaHead and Neck Cancer
BioVex Limited 5
Testing effectiveness (Phase 2)Study completedNCT01645748
What this trial is testing

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Chonnam National University Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00079079
What this trial is testing

Cisplatin or Carboplatin Combined With Gemcitabine in Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor

Who this might be right for
Head and Neck Cancer
NCIC Clinical Trials Group 34
Large-scale testing (Phase 3)UnknownNCT01216527
What this trial is testing

Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer

Who this might be right for
Squamous Cell Esophageal Carcinoma
Sun Yat-sen University 430
Early research (Phase 1)Ended earlyNCT03746431
What this trial is testing

[225Ac]-FPI-1434 Injection

Who this might be right for
Advanced Solid TumoursEndometrial CancerCervical Cancer+7 more
Fusion Pharmaceuticals Inc. 78
Testing effectiveness (Phase 2)UnknownNCT02812641
What this trial is testing

Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC

Who this might be right for
Stage III Esophageal Squamous Cell Carcinoma
National Taiwan University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07554521
What this trial is testing

Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States

Who this might be right for
Advanced Unresectable Gastric AdenocarcinomaEsophageal Squamous Cell CarcinomaAdvanced Gastroesophageal Adenocarcinoma
BeOne Medicines 30
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Testing effectiveness (Phase 2)Study completedNCT00016900
What this trial is testing

PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center
Not applicableLooking for participantsNCT07419932
What this trial is testing

Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid CancerThyroid Neoplasms
Fujian Medical University 120
Testing effectiveness (Phase 2)UnknownNCT01372111
What this trial is testing

Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Coastal Carolina Radiation Oncology 76
Testing effectiveness (Phase 2)Study completedNCT05302011
What this trial is testing

Neoadjuvant Pembrolizumab Plus Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 28
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Early research (Phase 1)Ended earlyNCT00903461
What this trial is testing

Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous Cell of Head and NeckSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma, Head And Neck
University of Pittsburgh 7
Next Page